M ore than 350,000 hip arthroplasties are performed every year in the United States alone, often resulting in significant postoperative pain. Reports of the use of posterior lumbar plexus local anesthetic infusions to provide analgesia after hip arthroplasty have increased dramatically within the last decade, 1-7 particularly after they were demonstrated to provide comparable analgesia to epidural infusions. 7 However, the recently published American Society of Regional Anesthesia (ASRA) guidelines now explicitly recommend the same precautions applied to neuroaxial techniques be exercised for deep peripheral nerve catheters, specifically that any catheter be removed before administration of various anticoagulants at certain doses (e.g., enoxaparin 30 mg twice daily). 8 Therefore, many patients are now precluded from receiving either a postoperative epidural or a continuous posterior lumbar plexus block.
One possible analgesic option is a continuous femoral nerve block in which the perineural catheter is inserted at the inguinal crease. 9 Unlike epidural or posterior lumbar plexus techniques, current ASRA guidelines allow for simultaneous administration of nearly any perioperative anticoagulant and a continuous femoral nerve block. 8 However, there is reason to question whether a perineural catheter inserted at the level of the inguinal crease will provide adequate analgesia after hip arthroplasty. 10, 11 Yet, if validated against the posterior lumbar plexus approach, the anterior femoral technique could be a viable option within ASRA guidelines for many patients undergoing hip arthroplasty. Data from 2 randomized trials comparing the continuous femoral and posterior lumbar plexus techniques failed to find one superior after knee arthroplasty, 12, 13 but it remains unclear whether a continuous femoral nerve block provides equivalent analgesia to the posterior option for hip arthroplasty.
We therefore tested the hypothesis that differing the catheter location (femoral versus posterior lumbar plexus) after hip arthroplasty has no impact on postoperative analgesia. The primary end point was the difference in mean pain scores during the 24-hour period beginning at 07:30 the morning after surgery, excluding twice-daily physical therapy sessions.
METHODS Enrollment
The local IRB (University of California San Diego, La Jolla, CA) approved all study procedures, and all participants provided written, informed consent. The trial was prospectively registered at clinicaltrials.gov (NCT00967980). Patients offered enrollment included adults (Ն18 years) scheduled for primary, unilateral hip arthroplasty via a 15to 25-cm curvilinear lateral skin incision centered over the greater trochanter. Exclusion criteria included a history of opioid dependence, abuse, or current chronic analgesic therapy (daily use Ͼ20 mg oxycodone-equivalent opioid use within the 2 weeks before surgery and duration of use Ͼ4 weeks); allergy to study medications; any neuromuscular deficit of the ipsilateral femoral nerve or quadriceps femoris muscle (including diabetic peripheral neuropathy); body mass index Ͼ40 kg/m 2 ; pregnancy; or incarceration.
Randomization
Subjects were randomized to 1 of 2 treatment groups, a femoral or a posterior lumbar plexus perineural catheter, using a computer-generated randomization table in blocks of 4, stratified by surgeon and surgical procedure (total or resurfacing), and based in a secure, password-protected, encrypted central server (www.PAINfRE.com). Subjects had their perineural catheter inserted before entering the operating room.
Ultrasound was used to scan the block area before needle insertion using a linear array transducer providing a frequency of 13-6 MHz (HFL38, SonoSite M-Turbo, Bothell, WA). Time for catheter placement started when the catheter-placement needle first touched the patient and ended when this needle was removed after catheter insertion for the posterior lumbar plexus group and after catheter tunneling for the femoral group. Catheters were inserted using techniques described previously, 14 -16 with the following revisions. An 8.9-or 15.0-cm, 17-gauge, insulated needle (StimuCath, Teleflex Medical, Research Triangle Park, NC) was inserted for both groups, and 5 mL of a solution of 5% dextrose in water was injected via the needle.
Femoral Catheter Insertion
Once the catheter was successfully inserted 5 cm past the needle tip, we continued to advance it up to 10 cm further. If the evoked motor response began to decrease, the catheter was withdrawn 1 cm to regain the original evoked motor response. The catheter was tunneled subcutaneously 6 to 8 cm medial and slightly cephalad.
Posterior Lumbar Plexus Catheter Insertion
The catheter was advanced 0 to 1 cm past the needle tip. If the evoked motor response decreased as the stimulating catheter was advanced, the catheter was withdrawn into the needle, the needle redirected, and the catheter then readvanced. The catheter was secured caudad and anterior to the ipsilateral axilla.
For both treatment groups, 20 mL of 1.5% mepivacaine (with 2.5 g/mL of epinephrine) was injected via the perineural catheter. Catheter placement was considered successful if, within 15 minutes, the patient experienced a decreased sensation to light touch over the ipsilateral distal thigh and weakness upon knee extension in relation to the contralateral limb. Patients without a successful catheter insertion had their catheters replaced or were withdrawn from the study.
Intraoperative Management
Patients were administered a standardized general anesthetic using inhaled sevoflurane, nitrous oxide, and oxygen via an endotracheal tube during surgery. A 0.2% ropivacaine infusion (6 mL/h basal; 4 mL bolus; 30-minute lockout) was initiated via the perineural catheter before the end of surgery via a portable infusion pump (PainPump2, Stryker Instruments, Kalamazoo, MI). Intravenous fentanyl was administered as needed during surgery, and IV hydromorphone was titrated to a respiratory rate of 12 to 14 just before emergence.
Postoperative Management
All patients received oral acetaminophen (975 mg every 6 hours), celecoxib (200 mg every 12 hours), and sustainedrelease oxycodone (Oxycontin, 10 mg every 12 hours). For breakthrough pain, patients depressed the infusion pump bolus button. When necessary, rescue opioid and route of administration were titrated to pain severity using a numeric rating scale (NRS) of 0 to 10 17 : mild pain (NRS Ͻ4): oral oxycodone 5 mg; moderate pain (NRS 4 to 7): oral oxycodone, 10 mg; and severe pain (NRS Ͼ7), IV hydromorphone, 0.5 mg. Patients underwent physical therapy twice daily beginning the morning after surgery at approximately 08:00 and 13:00. If the physical therapist believed subject ambulation was unacceptably limited because of quadriceps femoris weakness, the perineural infusion was stopped for 1 hour and then restarted with a new portable infusion pump at half the basal rate (3 mL/h) and bolus dose volume (2 mL). Subjects received deep vein thrombosis prophylaxis with 40 mg subcutaneous enoxaparin sodium once daily beginning the morning after surgery. This specific anticoagulant and dosing regimen may be used concurrently with a continuous posterior lumbar plexus block within the current ASRA guidelines. 8 
Outcome Measurements
All end points were recorded by nursing and physical therapy staff, as well as a research coordinator. The primary end point was the average of all pain scores recorded in the 24-hour period beginning at 07:30 the morning after surgery, excluding the periods of physical therapy. Pain measurements were evaluated using the 10-point NRS 17 and recorded every 4 hours (excluding periods of sleep), as well as immediately after physical therapy and upon analgesic request. Seven days after surgery, subjects were contacted by phone and asked about their satisfaction with postoperative analgesia before hospital discharge (0 to 10; 0 ϭ very unsatisfied and 10 ϭ very satisfied).
Statistical Analysis
Sample size estimation was based on our primary hypothesis that differing the catheter location (femoral versus posterior lumbar plexus) after hip arthroplasty has no impact on postoperative analgesia. To this end, we chose the mean NRS during the 24-hour period beginning at 07:30 the morning after surgery as the primary outcome variable to estimate a probable sample size. Because the aim of the study was to evaluate equivalency (owing to a proposed hypothesis of no group effect), standard inferential statistics used to demonstrate statistically significant nonzero effects do not strictly apply. Instead, we used the method described by Armitage et al. for equivalency trials whereby we concluded equivalence if the 95% confidence interval for the difference was within a tolerated interval. 18 We considered a difference of 1.6 on the NRS (1 SD) to be clinically relevant. 2 If the confidence interval was within Ϫ1.6 to 1.6 range, we concluded that the effect of the 2 treatments was equivalent. To calculate power, we simulated 10,000 trials with a total enrolled sample size of 50, assuming a SD in each group of 1.6 and 10% dropout. 2 This sample size provided 82% power to correctly conclude equivalence, and the probability of falsely concluding equivalence in the presence of a simulated group difference of 1.6 was 2.5% ("␣").
These analyses were executed using R version 2.11 (2010 
RESULTS
Fifty subjects were enrolled during a 10-month period beginning October 2009. Three subjects were withdrawn from the study before catheter insertion (exclusion criteria identified or the case cancelled after randomization). Of the remaining 47 subjects, 25 were randomized to receive a femoral perineural catheter, and 22 received a posterior lumbar plexus catheter, and these 2 groups were similar in demographic and surgical characteristics ( Table 1 ). All 47 subjects exhibited a sensory and motor block within 15 minutes after a local anesthetic bolus was administered via the catheter (Table 2 ).
Primary End Point
The mean (SD) pain scores for subjects receiving a femoral infusion (n ϭ 25) were 3.6 (1.8) versus 3.5 (1.8) for patients receiving a posterior lumbar plexus infusion (n ϭ 22), resulting in a group difference of 0.1 (95% confidence interval Ϫ0.9 to 1.2; P ϭ 0.78; Fig. 1 ). Because the confidence interval was within the prespecified Ϫ1.6 to 1.6 range, we conclude that the effects of the 2 treatments on postoperative pain were equivalent.
The prespecified primary end point was mean pain score over 24 hours. However, because pain scores were recorded every 4 hours during waking hours and on request of supplemental analgesics, the number of observations varied among subjects. Given this variability, it is not appropriate to assume that the mean pain score from each individual arises from the same distribution. A more appropriate way to estimate the mean pain score over the 24-hour period is with a mixed-effects model of the repeated hourly pain scores. 19 We fit such a model with a subject-specific random intercept, and fixed effects for the pain score at each hour and the difference in pain scores between the infusion groups. The estimated group difference from this model was 0.2 (95% confidence interval Ϫ0.9 to 1.3; P ϭ 0.77), which confirms the conclusions of the prespecified analysis.
Secondary End Points
Similarly, we detected no differences between the 2 treatments with respect to the secondary end points, with 1 a For power simulations and data analysis, confidence intervals were estimated using t.test() in the R package "stat. Values are reported as mean (SD) or number of subjects.
exception: subjects with a femoral catheter ambulated a median (10th-90th percentiles) 2 (0 -17) m the morning after surgery, in comparison with 11 (0 -31) m within the posterior lumbar plexus group (P ϭ 0.02; Table 3 ). However, pain scores between groups differed little during physical therapy: the means (SD) were 4.3 (2.9) versus 3.9 (2.7) in the morning for the femoral and posterior lumbar plexus groups, respectively (group difference 0.4; 95% confidence interval Ϫ1.2 to 2.1; P ϭ 0.65); and 3.4 (2.6) versus 3.3 (2.8) in the afternoon (group difference 0.1; 95% confidence interval Ϫ1.5 to 1.7; P ϭ 0.90). There were no patient falls in either treatment group. Satisfaction (0 to 10, 10 ϭ very satisfied) with analgesia during hospitalization was rated a median (10th-90th percentiles) of 8.0 (7.0 to 10.0) for subjects with a femoral infusion, in comparison with 10.0 (7.0 to 10.0) for those with a posterior lumbar plexus infusion (P ϭ 0.11). However, the average differences between groups were minimal, with the femoral and posterior lumbar plexus groups reporting a mean (SD) of 8.5 (1.2) and 9.2 (1.4), respectively (group difference Ϫ0.7; 95% confidence interval Ϫ1.5 to 0.1; P ϭ 0.11).
DISCUSSION
This investigation provides evidence that continuous femoral and posterior lumbar plexus blocks provide similar analgesia after hip arthroplasty. However, a posterior lumbar plexus perineural infusion appears to weaken the quadriceps femoris muscle to a lesser extent than a femoral infusion. 20 Although we did not directly measure quadriceps femoris strength, 21 ambulation distance the morning after surgery was greatly decreased with a femoral infusion; an observation reflected in 1 previous controlled study, 20 but not 2 others. 12, 13 In our study, 3 patients with femoral catheters had their basal infusion decreased the morning after surgery owing to weak quadriceps inhibiting ambulation per the physical therapist, in comparison with only 1 subject with a posterior lumbar plexus catheter (P ϭ 0.61). Because quadriceps femoris weakness is associated with significant functional disability 22 and an increased risk of falls in elderly patients, 23 it is postulated that any nerve block-induced muscular weakness is best minimized during perineural local anesthetic infusion. Both continuous femoral and posterior lumbar plexus blocks are associated with an increased risk of falling after knee and hip arthroplasty, respectively. 24 Figure 1 . Perineural catheter location, either a femoral or posterior lumbar plexus, effect on postoperative pain after hip arthroplasty with a ropivacaine 0.2% perineural infusion. Pain severity indicated using a numeric rating scale of 0 to 10, with 0 equal to no pain and 10 being the worst imaginable pain. Data include the 24-hour period beginning at 07:30 the morning after surgery. Data are expressed as median (horizontal bars) with 25th-75th (box) and 10th-90th (whiskers). The 95% confidence intervals for the estimated group differences were within prespecified tolerances and were therefore deemed equivalent. 
Previously Published Data
A similar study to ours was recently published, with somewhat different results. 20 The previous study involving unilateral hip arthroplasty found that, in comparison with a continuous femoral nerve block, a continuous posterior lumbar plexus block provides improved analgesia specifically during physical therapy the day after surgery (means of 3.5 and 5.8 on a visual analog scale; P Ͻ 0.05). In this previous study, the femoral catheter failed in providing dynamic analgesia to such a large degree that there was little difference between the group receiving a femoral perineural infusion and a third treatment group receiving only IV opioids (mean of 5.8 and 6.3; P value reported as Ͼ0.05). We believe that the differences between the previously published study and our current investigation may be explained with 4 differences in the study protocols.
First, in the previous study, an insulated needle was used to locate the femoral nerve, and a nonstimulating catheter advanced a full 10 cm past the needle tip for the femoral technique. 20 However, nonstimulating catheters advanced past the needle tip below the fascia iliaca do not reliably remain adjacent to the femoral nerve, 11 possibly accounting for the relatively poor dynamic analgesia in the femoral infusion group. 20 It was for this reason that we chose to use stimulating catheters in our study, because there are data suggesting that stimulating catheters may be placed, on average, closer to the target nerve/plexus in comparison with nonstimulating devices. [25] [26] [27] For hip arthroplasty, it is theoretically important to insert the catheter tip further cephalad in an attempt to deliver local anesthetic to the obturator and lateral femoral cutaneous nerves 28 ; therefore, we advanced the stimulating catheter up to 15 cm beyond the needle tip. We do not mean to suggest that the technique we used for our study reliably delivers the catheter tip to the lumbar plexus. However, published data do suggest that using a stimulating catheter versus a nonstimulating catheter permitted an increased degree of catheter insertion (up to 15 cm) while keeping the catheter tip adjacent to the femoral nerve. 11,21,25-27,29 -31 A second possible explanation for our differing results is that unlike the previously published study, 20 our protocol included a scheduled long-acting oral opioid (Oxycontin 10 mg twice daily). This analgesic probably decreased any differences in dynamic analgesia between the 2 treatment groups (as well as increased possible opioid-related side effects). 20 In addition, the previous study used a higher basal infusion rate (10.5 vs. 6.0 mL/h for a 70-kg subject), which may have increased the effectiveness of the posterior lumbar plexus, but not femoral infusions. We chose a 6 mL/h basal rate because 2 previous investigations reported 42%-43% of patients receiving femoral or posterior lumbar plexus perineural ropivacaine 0.2% at 8 mL/h experienced quadriceps femoris weakness requiring a decrease in the basal infusion rate, 2,32 and a possible increased risk of falls. 24 Last, whereas the previous study recorded pain scores specifically at rest, 20 we collected pain scores at all times other than physical therapy sessions (every 4 hours and upon analgesic request). This protocol results in a more global reflection of subjects' experiences in the postoperative period, and not simply "at rest."
Study Limitations
Subjects, clinical personnel, and investigators were not masked to treatment group. In addition, the current findings involved patients undergoing unilateral hip arthroplasty, and may not be applicable to other surgical procedures of the hip joint. Finally, the results of this study are specific to the catheter-insertion protocol and subsequent perineural infusion protocol described above. Whether our findings remain valid for alternative protocols (e.g., in-plane ultrasound-guided catheter insertion and bupivacaine infusion) remains unknown. . The NIH grant provided funding for 80% nonclinical time in addition to specific randomized, controlled trials (also involving ambulatory perineural local anesthetic infusion). Five years of protected research time allowed me to take a dozen additional didactic courses to build upon knowledge gained during my Master's Degree training; develop skills in designing, executing, and reporting multicenter clinical trials; work with and learn from incredibly talented co-investigators; serve as an editor for my subspecialty's journal Regional Anesthesia and Pain Medicine; successfully compete for additional research funding; and, help mentor wonderfully gifted and enthusiastic fellows and faculty members with whom I have been so blessed to cross paths. Most importantly, it gave me the opportunity to work and/or study with extraordinary mentors such as Drs. Kayser Enneking, Nikolaus Gravenstein, Daniel Sessler, Joseph Neal, James Eisenach, Tony Yaksh, and Pamela Duncan, among so many others. Now, 90% of my workweek involves clinical research; and, I am very fortunate to serve as the Director of Clinical Research for my Section at the University of California San Diego, on the Advisory Board of the UCSD Clinical and Translational Research Institute, and as a reviewer for NIH Special Emphasis Panel/Scientific Review Groups. There is no doubt in my mind that without the investment FAER made in me nearly a decade ago, I would have been able to attain only a small fraction of my career goals. For this, I am, and will for always be, deeply grateful.
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